We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Avacta | LSE:AVCT | London | Ordinary Share | GB00BYYW9G87 | ORD 10P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -2.10 | -6.25% | 31.50 | 2,295,097 | 15:37:04 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 31.00 | 32.00 | 33.50 | 31.50 | 33.50 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 24.42M | -52.84M | -0.1356 | -2.32 | 130.97M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 16:43:31 | O | 150,000 | 31.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 09/6/2025 | 17:15 | UK RNS | Avacta Group PLC Posting of Annual Report and Revised Notice of AGM |
| 06/6/2025 | 10:50 | ALNC |  Avacta revenue falls, sees "transformative" year after repositioning |
| 06/6/2025 | 07:00 | UK RNS | Avacta Group PLC Preliminary Full Year 2024 Results |
| 04/6/2025 | 07:00 | UK RNS | Avacta Group PLC Avacta Change in Prelim Date Part 2 |
| 28/5/2025 | 07:00 | UK RNS | Avacta Group PLC Board appointments |
| 27/5/2025 | 07:00 | UK RNS | Avacta Group PLC Update on timing of preliminary results |
| 15/5/2025 | 07:00 | UK RNS | Avacta Group PLC Notice of Results |
| 12/5/2025 | 12:00 | UK RNS | Avacta Group PLC Investor Webinar |
| 08/5/2025 | 07:30 | UK RNS | Avacta Group PLC Block Listing Application to AIM |
| 29/4/2025 | 07:00 | UK RNS | Avacta Group PLC Board change |
Avacta (AVCT) Share Charts1 Year Avacta Chart |
|
1 Month Avacta Chart |
Intraday Avacta Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 16/6/2025 | 17:19 | Avacta – Innovative and Disruptive Technologies for Global Health Markets | 59,224 |
| 25/6/2024 | 12:57 | Covid-19. Ten Minute Test. Gamechanger!! | 19,644 |
| 23/4/2024 | 13:44 | avct The Fall!!! | 141 |
| 23/4/2023 | 22:31 | Avacta – Unique and innovative technology blipping on big pharma’s radar | 1,851 |
| 23/2/2022 | 07:14 | CV And The Deep State | 228 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 15:43:32 | 31.00 | 150,000 | 46,500.00 | O |
| 15:43:30 | 31.00 | 100,000 | 31,000.00 | O |
| 15:28:20 | 31.95 | 1,000 | 319.50 | O |
| 15:26:28 | 31.95 | 1,000 | 319.50 | O |
| 15:26:05 | 31.70 | 90,000 | 28,530.00 | O |
| Top Posts |
|---|
Posted at 04/6/2025 09:19 by cheshire pete Deathly silence from the usual suspects. Thought they'd have their tails up with the delay till friday. Delays often due to bad news but share price now rising so what's going on....hmmm. |
Posted at 28/5/2025 15:17 by rubstick I am a genuine supporter of this share and have followed it from around 2014. But I cannot see how todays news is worth a 14% increase in share price please enlighten me. My reading is they have brought in 2 Capital Markets guys. Big deal those guys can access capital, which we all know is the issue here. But they cannot magic it from nowhere. I am of the opinion that the company is still too early stage to be taken over. So what are their options? The only one I see is a major rights issue. |
Posted at 23/4/2025 08:55 by 1347 Yes I've checked and Whitey was wrong (tut, tut), it's 32.07462p. That's still well down from the first conversion price though. The corrupt AIM MMs & Brokers will try and keep the share price up for a while though to try flip the latest confetti shares to the retail mugs (expect another powder puff RNS to help with that) but then, barring a miracle breakthrough or something like it, the share price will likely drift down sub 30p quite soon. |
Posted at 21/11/2024 11:20 by m_night10 POLX FDA Approval received today big rise comingPOLX Polarean Imaging 1.6p I fancy to fill the gap to 3.2p and head to 10p+. Mcap is peanuts and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil in 2025 Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations. Putting this UK recovery play potential on radars as used to trade at 100p and has made significant commercial progress since FDA approval. Massive takeover target and will be sold for 20p+ share price. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice. |
Posted at 20/11/2024 08:24 by m_night10 POLX Polarean Imaging 1.6p I fancy to fill the gap to 3.2p and head to 10p+. Mcap is peanuts 1/10th of AVCT and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil in 2025 Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations.Putting this UK recovery play potential on radars as used to trade at 100p and has made significant commercial progress since FDA approval. Massive takeover target and will be sold for 20p+ share price. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice. |
Posted at 13/11/2024 08:33 by m_night10 POLX Polarean Imaging about to break out above 2p soon. Mcap is peanuts and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.55p and gap at over 3p. ATH 100p. Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations.Putting this UK recovery play potential on radars. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice. |
Posted at 12/11/2024 07:50 by m_night10 POLX Polarean Imaging will break out above 2p soon. Mcap only $20mil. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.55p and gap at over 3p. ATH 100p. Cash runway to minimum of Q1 2026, looks set to be extended given revenues ahead of expectations.Putting this UK recovery play potential on radars. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target imv. DYOR, not advice. |
Posted at 08/11/2024 07:32 by m_night10 POLX Polarean Imaging about to break out above 2p soon. Mcap only $25mil. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.65p and gap at over 3p. ATH 100p. Cash runway to minimum of Q1 2026, looks set to be extended given revenues ahead of expectations.Putting this UK recovery play potential on radars. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target imv. DYOR, not advice. |
Posted at 12/9/2024 19:09 by waldron THE AVCT SHARE PRICEAnd when they were up they were up, And when they were down they were down, And when they were only half way up They were neither up nor down. RESULTS SHOULD SOON CLARIFY share price DIRECTION GOOD LUCK ALL |
Posted at 04/7/2024 11:35 by jaknife PWhite73,"The rise in the share price reflects a more credible management team and a more effective PR campaign." The rise in the share price simply reflects the market maker moving the share price up. People assume that buying activity has moved the share price up but that's not necessarily how markets work. The easiest way to encourage buying activity is to create the illusion of momentum first! There's a conversion due on the death spiral in just over two weeks time and hence the market maker needs to sell something like 5m shares between now and then. JakNife |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
